YTHDF2 and ovarian cancer: Collectively, we demonstrate that YTHDF2 may drive ovarian cancer development, and that FBW7 restrains ovarian carcinogenesis by inducing proteolytic degradation and thus compromising the oncogenic activity of YTHDF2.